This company listing is no longer active
AlerisLife Past Earnings Performance
Past criteria checks 0/6
Key information
15.2%
Earnings growth rate
44.4%
EPS growth rate
Healthcare Industry Growth | 8.5% |
Revenue growth rate | -37.9% |
Return on equity | -24.5% |
Net Margin | -23.7% |
Last Earnings Update | 30 Sep 2022 |
Recent past performance updates
Recent updates
AlerisLife names new operations chief
Oct 17AlerisLife appoints Heather Pereira as senior VP, CFO and Treasurer
Sep 19Is AlerisLife (NASDAQ:ALR) Using Too Much Debt?
Mar 01AlerisLife Still Needs To Execute Despite Wall Street Bullishness
Feb 28Five Star: A Professional Opportunity For The Retail Investor
Oct 29Five Star Senior Living: The $3.80 Level Most Likely The Bottom
Sep 22Five Star Senior Living: Buy Your Winter Coats In Summer
Jul 26Is Now The Time To Look At Buying Five Star Senior Living Inc. (NASDAQ:FVE)?
May 09Five Star Senior Living Inc. 2021 Q1 - Results - Earnings Call Presentation
May 06Five Star Senior Living (NASDAQ:FVE) Seems To Use Debt Quite Sensibly
Apr 12Analysts Are Optimistic We'll See A Profit From Five Star Senior Living Inc. (NASDAQ:FVE)
Mar 14What Is The Ownership Structure Like For Five Star Senior Living Inc. (NASDAQ:FVE)?
Feb 16Five Star Senior Living's (NASDAQ:FVE) Shareholders Are Down 71% On Their Shares
Jan 29Is Five Star Senior Living (NASDAQ:FVE) Using Too Much Debt?
Jan 12Should You Think About Buying Five Star Senior Living Inc. (NASDAQ:FVE) Now?
Dec 25Five Star Senior Living: Additional Upside Looks Probable
Dec 16Has Five Star Senior Living Inc.'s (NASDAQ:FVE) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Dec 07Are Five Star Senior Living's (NASDAQ:FVE) Statutory Earnings A Good Guide To Its Underlying Profitability?
Nov 19Five Star Senior Living Inc. 2020 Q3 - Results - Earnings Call Presentation
Nov 08Revenue & Expenses BreakdownBeta
How AlerisLife makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 22 | 160 | -38 | 76 | 0 |
30 Jun 22 | 161 | -39 | 81 | 0 |
31 Mar 22 | 168 | -43 | 86 | 0 |
31 Dec 21 | 180 | -30 | 90 | 0 |
30 Sep 21 | 193 | -16 | 90 | 0 |
30 Jun 21 | 205 | -2 | 89 | 0 |
31 Mar 21 | 213 | 13 | 88 | 0 |
31 Dec 20 | 222 | -8 | 89 | 0 |
30 Sep 20 | 437 | 6 | 104 | 0 |
30 Jun 20 | 656 | -5 | 136 | 0 |
31 Mar 20 | 880 | -4 | 159 | 0 |
31 Dec 19 | 1,101 | -20 | 217 | 0 |
30 Sep 19 | 1,114 | -60 | 250 | 0 |
30 Jun 19 | 1,116 | -74 | 269 | 0 |
31 Mar 19 | 1,112 | -99 | 295 | 0 |
31 Dec 18 | 1,110 | -74 | 286 | 0 |
30 Sep 18 | 1,112 | -51 | 285 | 0 |
30 Jun 18 | 1,119 | -36 | 283 | 0 |
31 Mar 18 | 1,128 | -22 | 283 | 0 |
31 Dec 17 | 1,136 | -21 | 282 | 0 |
30 Sep 17 | 1,138 | -26 | 281 | 0 |
30 Jun 17 | 1,137 | -25 | 281 | 0 |
31 Mar 17 | 1,139 | -26 | 278 | 0 |
31 Dec 16 | 1,136 | -22 | 275 | 0 |
30 Sep 16 | 1,135 | -22 | 272 | 0 |
30 Jun 16 | 1,135 | -43 | 269 | 0 |
31 Mar 16 | 1,130 | -38 | 269 | 0 |
Quality Earnings: ALR is currently unprofitable.
Growing Profit Margin: ALR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ALR is unprofitable, but has reduced losses over the past 5 years at a rate of 15.2% per year.
Accelerating Growth: Unable to compare ALR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ALR is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-12.4%).
Return on Equity
High ROE: ALR has a negative Return on Equity (-24.48%), as it is currently unprofitable.